Diagnosis and clinical virology of Lassa fever as evaluated by enzyme- linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation

Journal of Clinical Microbiology

Volumn 38, Issue 7, 2000, Pages 2670-2677

  Bausch, D G ^a,d   Rollin, P E ^a   Demby, A H ^a,d   Coulibaly, M ^b   Kanu, J ^a   Conteh, A S ^c   Wagoner, K D ^a   McMullan, L K ^a   Bowen, M D ^a,d   Peters, C J ^a   Ksiazek, T G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Inst Rech Biol Appl et de Guinee   (Guinea)

^c Kenema Government Hospital   (Sierra Leone)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INTERMETHOD COMPARISON; LASSA FEVER; LASSA VIRUS; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION;

ARENAVIRUS; LASSA VIRUS; RNA VIRUSES;

EID: 0033914772     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.7.2670-2677.2000     Document Type: Article

References (30)

1. Arnold, R. B., and G. W. Gary, Jr. 1977. A neutralization test survey for Lassa fever activity in Lassa, Nigeria. Trans. R. Soc. Trop. Med Hyg. 71: 152-154.
2. Bloch, A. 1978. A serological survey of Lassa fever in Liberia. Bull. W. H. O. 56:811-813.
3. Bowen, M. D., C. J. Peters, and S. T. Nichol. 1997. Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between Arenaviruses and their rodent hosts. Mol. Phylogenet. Evol. 8:301-316.
4. Buchmeier, M., R. Welsh, F. Dutko, and M. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275-331.
5. Byrne, J., R. Ahmed, and M. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants. J. Immunol. 133:433-439.
6. Demby, A. H., J. Chamberlain, D. W. G. Brown, and C. S. Clegg. 1994. Early diagnosis of Lassa fever by reverse transcription-PCR. J. Clin. Microbiol. 32:2898-2903.
7. Fisher-Hoch, S. P., S. Gborie, L. Parker, and J. Huggins. 1992. Unexpected adverse reactions during a clinical trial in rural West Africa. Antivir. Res. 19:139-147.
8. Fisher-Hoch, S. P., O. Tomori, A. Nasidi, G. I. Perez-Oronoz, Y. Fakile, L. Hutwagnor, and J. B. McCormick. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br. Med. J. 311:857-859.
9. Frame, J. D., J. M. Baldwin, D. J. Gocke, and J. M. Troup. 1970. Lassa fever, a new disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg. 19:670-676.
10. Frame, J. D. 1989. Clinical features of Lassa fever in Liberia. Rev. Infect. Dis. 11:S783-S789.
11. Ivanov, A. P., E. A. Tkachenko, G. van der Groen, A. M. Butneko, and O. K. Konstantinov. 1986. Indirect enzyme-immunoassay for the laboratory diagnosis of Lassa and Ebola hemorrhagic fevers. Vopr. Virusol. 2:186-190.
12. Jahrling, P. B., R. A. Hesse, G. A. Eddy, K. M. Johnson, R. T. Callis, and E. L. Stephen. 1980. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis. 141:580-589.
13. Jahrling, P. B., B. S. Niklasson, and J. B. McCormick. 1985. Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody. Lancet i:250-252.
14. Johnson, K. M., J. B. McCormick, P. A. Webb, E. S. Smith, L. H. Elliott, and I. J. King. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-464.
15. Kochhar, D. M. 1990. Effects of exposure to high concentrations of ribavirin in developing embryos. Pediatr. Infect. Dis. 9:S88-S90.
16. Lunkenheimer, K., F. T. Hufert, and H. Schmitz. 1990. Detection of Lassa virus RNA specimens from patients with Lassa fever by using the polymerase chain reaction. J. Clin. Microbiol. 28:2689-2692.
17. McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, E. S. Smith, S. Trippel, and T. C. Tong. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
18. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont-Williams. 1986. Lassa fever: effective therapy with Ribavirin. N. Eng. J. Med. 314:20-26.
19. Mertens, P. E., R. Patton, J. J. Baum, and T. P. Monath. 1973. Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am. J. Trop. Med. Hyg. 22:780-784.
20. Monath, T. P., M. Maher, J. Casals, R. E. Kissling, and A. Cacciapuoti. 1974. Lassa fever in the eastern province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am. J. Trop. Med. Hyg. 23:1140-1149.
21. Monson, M. H., J. D. Frame, P. B. Jahrling, and K. Alexander. 1984. Endemic Lassa fever in Liberia. I. Clinical and epidemiologic aspects at Curran Lutheran Hospital, Zorzor, Liberia. Trans. R. Soc. Med. Hyg. 78: 549-553.
22. Niklasson, B. S., P. B. Jahrling, and C. J. Peters. 1984. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 20:239-244.
23. Ning, Q., D. Brown, J. Parodo, M. Cattral, R. Gorczynski, E. Cole, L. Fung, J. W. Ding, M. F. Liu, O. Rotstein, J. M. Phillips, and G. Levy. 1998. Ribavirin inhibits viral-induced macrophage production of TNG, IL-1, the procoagulant fg12 prothromhinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 160:3487-3493.
24. Stephenson, E. H., E. W. Larson, and J. W. Dominik. 1984. Effect of environmental factors on aerosol-induced Lassa virus infection. J. Med. Virol. 14:295-303.
25. Ter Meulan, J., K. Koulemou, T. Wittekindt, K. Windisch, S. Strigl, S. Conde, and H. Schmitz. 1998. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J. Clin. Microbiol. 36:3143-3148.
26. Trappier, S. G., A. L. Conaty, B. B. Farrar, D. D. Auperin, J. B. McCormick, and S. P. Fisher-Hoch. 1993. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am. J. Trop. Med. Hyg. 49:214-221.
27. Van der Waals, F. W., K. L. Pomeroy, J. Goudsmit, D. M. Asher, and D. C. Gajdusek. 1986. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop. Geogr. Med. 38:209-214.
28. White, H. A. 1972. Lassa fever: a study of 23 hospital cases. Trans. R. Soc. Med. Hyg. 66:390-398.
29. Wulff, H., and K. M. Johnson. 1979. Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections. Bull. W. H. O. 57:631-635.
30. Wulff, H., and J. V. Lange. 1975. Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull. W. H. O. 52:429-436.